COVID-19-associated mucormycosis: Case report and systematic review
A Dilek, R Ozaras, S Ozkaya, M Sunbul, EI Sen… - Travel medicine and …, 2021 - Elsevier
Background Increasing number of patients with COVID-19-associated mucormycosis have
been reported, especially from India recently. We have described a patient with COVID-19 …
been reported, especially from India recently. We have described a patient with COVID-19 …
COVID‐19‐associated mucormycosis: an updated systematic review of literature
In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
COVID-19 and mucormycosis superinfection: the perfect storm
JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
COVID-19-associated mucormycosis presenting to the Emergency Department—an observational study of 70 patients
Background Mucormycosis (MM) is a deadly opportunistic fungal infection and a large surge
in COVID-19-associated mucormycosis (CAM) is occurring in India. Aim Our aim was to …
in COVID-19-associated mucormycosis (CAM) is occurring in India. Aim Our aim was to …
[HTML][HTML] Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: a case series
Background: Coronavirus disease (COVID-19) remains a health concern with new
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …
global attention. However, basic epidemiologic characteristics have not firmly been …
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
AJ Rodriguez-Morales, R Sah… - Therapeutic …, 2021 - journals.sagepub.com
Therapeutic Advances in Infectious Disease 8 2 journals. sagepub. com/home/tai caring for
patients with COVID-19, the empiric overuse of corticosteroids has been associated with …
patients with COVID-19, the empiric overuse of corticosteroids has been associated with …
COVID-19-associated mucormycosis (CAM): an updated evidence mapping
Mucormycosis, a serious and rare fungal infection, has recently been reported in COVID-19
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
[HTML][HTML] COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review
A Al Balushi, A Al Ajmi, Q Al Sinani, V Menon… - International Journal of …, 2022 - Elsevier
Background A surge in COVID-19-associated mucormycosis cases has been observed
during the second wave of COVID-19 in summer of 2021. Most cases were reported from …
during the second wave of COVID-19 in summer of 2021. Most cases were reported from …